EUKEDOS risk profile

44 Elevated one input has moved against it

Measured 1 September 2026 from EUK.MI's filed statements. Recomputed nightly.

44 (Elevated), driven by Leverage and coverage at 91, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation70StretchedStableDrawdown from the 52-week high — 37.0%
Operating pressure37NormalStableCosts outgrowing revenue — -0.5 percentage points
Cash conversion67StretchedEasingCapital spending against operating cash — 0.93x
Leverage and coverage91AcuteWorseningNet debt to EBITDA — 11.46x
Competitive position21NormalStableRevenue-growth gap against peers — +2.2 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for EUKEDOS